兰州大学机构库

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study 期刊论文
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 卷号: 20, 期号: 3, 页码: 716-728
Authors:  Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda...Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda;  Hou, Ming;  Yao, Yazhou;  Liu, Li;  Wang, Yi;  Wu, Depei;  Zhang, Liansheng;  Zheng, Changcheng;  Shen, Xuliang;  Hu, Qi;  Liu, Jing;  Jin, Jie;  Luo, Jianmin;  Zeng, Yun;  Gao, Sujun;  Zhang, Xiaohui;  Zhou, Xin;  Shi, Qingzhi;  Xia, Ruixiang;  Xie, Xiaobao;  Jiang, Zhongxing;  Gao, Li;  Bai, Yuansong;  Xiong, Junye;  Li, Runzi;  Zou, Jianjun;  Niu, Ting;  Yang, Renchi;  Hu, Yu
Favorite  |    Submit date:2022/04/20
extension period  hetrombopag  immune thrombocytopenia  platelet response  thrombopoietin receptor agonist  withdrawal  
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 卷号: 14, 期号: 1
Authors:  Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda...Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda;  Hou, Ming;  Yao, Yazhou;  Liu, Li;  Wang, Yi;  Wu, Depei;  Zhang, Liansheng;  Zheng, Changcheng;  Shen, Xuliang;  Hu, Qi;  Liu, Jing;  Jin, Jie;  Luo, Jianmin;  Zeng, Yun;  Gao, Sujun;  Zhang, Xiaohui;  Zhou, Xin;  Shi, Qingzhi;  Xia, Ruixiang;  Xie, Xiaobao;  Jiang, Zhongxing;  Gao, Li;  Bai, Yuansong;  Li, Yan;  Xiong, Junye;  Li, Runzi;  Zou, Jianjun;  Niu, Ting;  Yang, Renchi;  Hu, Yu
Favorite  |    Submit date:2021/04/16
Immune thrombocytopenia  Hetrombopag  Thrombopoietin receptor agonists  Platelet response  
Iron Chelation of Hetrombopag in Aplastic Anemia: A Post Hoc Analysis of a Phase II Study 会议论文
AMER SOC HEMATOLOGY, New Orleans, LA, DEC 10-13, 2022
Authors:  Yang, Wenrui;  Zhao, Xin;  He, Guangsheng;  Chang, Hong;  Han, Bing;  Gao, Sujun;  Wang, Shunqing;  Chen, Tong;  Li, Fei;  Wang, Yi...Yang, Wenrui;  Zhao, Xin;  He, Guangsheng;  Chang, Hong;  Han, Bing;  Gao, Sujun;  Wang, Shunqing;  Chen, Tong;  Li, Fei;  Wang, Yi;  Ge, Xiaoyan;  Fu, Rong;  Ge, Zheng;  Li, Yingmei;  Liu, Hong;  Liu, Xinjian;  Miao, Miao;  Zhang, Liansheng;  Zhang, Fengkui
Favorite  |    Submit date:2023/04/12
Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study 期刊论文
ANNALS OF HEMATOLOGY, 2022, 卷号: 101, 期号: 12, 页码: 2611-2616
Authors:  Yang, Wenrui;  Zhao, Xin;  He, Guangsheng;  Chang, Hong;  Han, Bing;  Gao, Sujun;  Wang, Shunqing;  Chen, Tong;  Li, Fei;  Wang, Yi...Yang, Wenrui;  Zhao, Xin;  He, Guangsheng;  Chang, Hong;  Han, Bing;  Gao, Sujun;  Wang, Shunqing;  Chen, Tong;  Li, Fei;  Wang, Yi;  Ge, Xiaoyan;  Fu, Rong;  Ge, Zheng;  Li, Yingmei;  Liu, Hong;  Liu, Xinjian;  Miao, Miao;  Zhang, Liansheng;  Zhang, Fengkui
Adobe PDF(1344Kb)  |  Favorite  |    Submit date:2022/11/09
Aplastic anemia  Hetrombopag  Iron chelation  
YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial 期刊论文
FRONTIERS IN MEDICINE, 2021, 卷号: 8
Authors:  Liu, Weiping;  Li, Yufu;  Wang, Quanshun;  Su, Hang;  Ding, Kaiyang;  Shuang, Yuerong;  Gao, Sujun;  Zou, Dehui;  Jing, Hongmei;  Chai, Ye...Liu, Weiping;  Li, Yufu;  Wang, Quanshun;  Su, Hang;  Ding, Kaiyang;  Shuang, Yuerong;  Gao, Sujun;  Zou, Dehui;  Jing, Hongmei;  Chai, Ye;  Zhang, Yicheng;  Liu, Lihong;  Wang, Chunling;  Liu, Hui;  Lin, Jinying;  Zhu, Haiyan;  Yao, Chen;  Yan, Xiaoyan;  Shang, Meixia;  Wang, Shufang;  Chang, Fengyuan;  Wang, Xiaopei;  Zhu, Jun;  Song, Yuqin
Favorite  |    Submit date:2021/04/16
hematopoietic stem cell mobilization  therapeutics  treatment outcome  safety  lymphoma  non-Hodgkin  
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study 期刊论文
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 卷号: 98, 期号: 11, 页码: 1742-1750
Authors:  Deng, Lijuan;  Li, Zhiming;  Zhang, Huilai;  Huang, Haiwen;  Hu, Jianda;  Liu, Lihong;  Liu, Ting;  Jin, Jie;  Zhu, Zunmin;  Li, Wenyu...Deng, Lijuan;  Li, Zhiming;  Zhang, Huilai;  Huang, Haiwen;  Hu, Jianda;  Liu, Lihong;  Liu, Ting;  Jin, Jie;  Zhu, Zunmin;  Li, Wenyu;  Huang, Zhenqian;  Huang, Wenrong;  Zhou, Keshu;  Yang, Haiyan;  Zhang, Mingzhi;  Ding, Kaiyang;  Zhou, Hui;  Hu, Yu;  Shuang, Yuerong;  Cao, Junning;  Gao, Sujun;  Li, Dengju;  Sun, Zimin;  Zhang, Qingyuan;  Yi, Shuhua;  Ji, Chunyan;  Zhang, Liansheng;  Hou, Cheng;  Du, Yue;  Wang, Weige;  Zhao, Renbin;  Song, Yuqin;  Zhu, Jun
Favorite  |    Submit date:2023/11/28